CN Stock MarketDetailed Quotes

688526 Wuhan Keqian Biology Co.,Ltd

Watchlist
  • 15.70
  • +0.43+2.82%
Market Closed Nov 7 15:00 CST
7.32BMarket Cap24.45P/E (TTM)

Wuhan Keqian Biology Co.,Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Assets
Current assets
Money funds
-42.48%398.15M
64.50%688.95M
10.24%800.29M
27.56%581.74M
49.61%692.16M
-31.79%418.82M
32.74%725.98M
-17.88%456.07M
-77.13%462.63M
-67.69%614M
Transactional financial assets
-26.64%667.65M
-18.63%645.32M
13.03%695.12M
10.40%745.04M
69.15%910.04M
188.48%793.04M
153.12%614.96M
216.90%674.83M
156.20%538.01M
30.91%274.9M
Notes receivable and accounts receivable
-15.50%334.41M
-28.16%297.76M
-24.10%312.35M
-18.45%331.41M
-5.23%395.76M
16.90%414.46M
46.90%411.54M
47.62%406.38M
85.23%417.61M
86.60%354.54M
-Notes receivable
----
----
----
----
----
-58.43%43.37M
448.59%70.31M
1,005.53%82.67M
211.88%105.47M
1,400.67%104.32M
-Accounts receivable
-15.50%334.41M
-19.76%297.76M
-8.46%312.35M
2.38%331.41M
26.79%395.76M
48.31%371.1M
27.64%341.23M
20.87%323.71M
62.88%312.14M
36.70%250.22M
Other receivables (including interest and dividends)
41.26%4.82M
17.33%4.9M
-6.99%3.89M
42.19%3.73M
52.92%3.41M
-17.28%4.18M
-5.31%4.18M
1.50%2.62M
-33.01%2.23M
46.92%5.05M
-Other receivable
----
17.33%4.9M
----
42.19%3.73M
----
-17.28%4.18M
----
1.50%2.62M
----
46.92%5.05M
Advance payment
-37.94%4.34M
-61.71%3.83M
-65.83%3.69M
-15.72%7.69M
-43.36%6.99M
5.68%10M
2.18%10.8M
-11.30%9.12M
-69.20%12.35M
-59.67%9.46M
Inventories
-29.26%110.57M
-18.21%133.64M
-15.70%146.44M
-14.52%144.8M
17.09%156.31M
35.99%163.4M
47.86%173.71M
55.68%169.4M
16.02%133.49M
14.12%120.16M
Receivable financing
--610
--5.28M
-100.00%10
8,256.80%11.74M
----
----
-82.23%2.84M
-99.27%140.44K
--2M
--2.02M
Non-current assets due within one year
-0.50%804.68M
-23.89%753.58M
-42.74%484.15M
-44.35%468.74M
162.06%808.71M
1,256.01%990.17M
47.32%845.47M
46.04%842.33M
--308.59M
--73.02M
Other current assets
--71.95M
--38.09M
--26.85M
--271.2M
----
----
----
----
----
----
Total current assets
-19.40%2.4B
-7.97%2.57B
-11.35%2.47B
0.20%2.57B
58.42%2.97B
92.28%2.79B
55.63%2.79B
45.40%2.56B
-28.30%1.88B
-40.26%1.45B
Non Current assets
Other equity investment
46,910.29%94.02M
50,370.91%100.94M
49,846.86%99.89M
48,185.89%96.57M
33.33%200K
33.33%200K
33.33%200K
33.33%200K
0.00%150K
50.00%150K
Fixed assets
----
-9.97%755.65M
----
-9.27%799.01M
----
8.10%839.29M
----
70.85%880.59M
----
48.49%776.4M
Constru in process
----
693.78%74.7M
----
153.25%43.05M
----
-93.89%9.41M
----
-95.63%17M
----
-25.25%154.14M
Productive biological assets
-3.23%8.7M
--7.51M
--8.77M
--10.05M
--8.99M
----
----
----
----
----
Intangible assets
1.18%59.57M
-0.63%57.66M
-0.76%58.52M
0.19%60.03M
4.16%58.87M
0.96%58.03M
2.64%58.97M
4.67%59.91M
0.18%56.52M
3.06%57.47M
Goodwill
0.00%3.31M
0.00%3.31M
0.00%3.31M
0.00%3.31M
0.00%3.31M
0.00%3.31M
--3.31M
--3.31M
--3.31M
--3.31M
Long deferred expense
--1.21M
--1.04M
--1.11M
--1.18M
----
----
----
----
----
----
Deferred tax assets
-99.46%189.36K
-99.23%246.87K
-98.25%505.2K
-98.88%299.89K
51.21%34.86M
64.13%31.87M
61.16%28.9M
64.69%26.8M
15.98%23.06M
18.65%19.42M
Usufruct assets
-12.83%6.03M
-12.13%6.33M
-11.91%6.61M
-12.82%6.79M
6.20%6.92M
7.30%7.21M
--7.5M
--7.79M
--6.51M
--6.72M
Other non current assets
25.48%1.02B
13.19%892.11M
24.95%1.14B
30.06%1.08B
-33.97%811.77M
-43.51%788.13M
-12.86%910.66M
-15.42%834.13M
1,867.06%1.23B
1,403.47%1.4B
Total non current assets
15.36%2.04B
9.33%1.9B
13.96%2.15B
15.05%2.11B
-21.07%1.76B
-27.99%1.74B
-6.90%1.88B
-6.84%1.83B
118.19%2.24B
169.84%2.41B
Total assets
-6.45%4.43B
-1.34%4.47B
-1.15%4.62B
6.39%4.67B
15.21%4.74B
17.22%4.53B
22.48%4.67B
17.86%4.39B
12.90%4.11B
16.21%3.87B
Liabilities
Current liabilities
Short term loan
-75.00%57.04M
-15.12%202.13M
-37.52%155.08M
57.02%206.65M
225.67%228.16M
693.18%238.15M
2,378.61%248.19M
629.98%131.6M
45.74%70.06M
-25.02%30.03M
Notes payable and accounts payable
-24.92%135.18M
-34.48%123.55M
-45.80%120.83M
-32.44%165.03M
-29.47%180.04M
-22.58%188.58M
1.15%222.92M
13.22%244.27M
13.44%255.27M
49.09%243.59M
-Notes payable
-54.02%18.51M
-20.59%17.48M
-59.83%17.06M
-31.88%32.69M
17.03%40.24M
-45.05%22.01M
85.22%42.47M
142.93%47.99M
89.88%34.39M
653.76%40.05M
-Accounts payable
-16.54%116.67M
-36.32%106.08M
-42.50%103.76M
-32.58%132.34M
-36.71%139.79M
-18.16%166.57M
-8.61%180.44M
0.15%196.27M
6.75%220.89M
28.76%203.54M
Contract liabilities
-13.39%179.48M
25.88%172.48M
5.24%203.85M
54.97%157.61M
31.96%207.22M
63.25%137.02M
37.85%193.69M
60.96%101.7M
-21.95%157.03M
-23.52%83.93M
Salaries payable
-6.47%41.06M
-5.44%30.67M
-18.24%20.59M
0.33%49.57M
29.10%43.9M
10.68%32.44M
53.28%25.18M
0.73%49.41M
-26.00%34M
-28.49%29.31M
Taxs payable
-37.75%29.08M
-25.46%21.23M
184.43%63.18M
57.14%57.82M
88.56%46.71M
346.79%28.48M
14.24%22.21M
-31.64%36.79M
-43.78%24.77M
-43.99%6.38M
Other payable (including interest and dividends)
-26.75%40.74M
-22.25%37.97M
-24.36%40.3M
-32.67%39.64M
41.06%55.62M
30.96%48.84M
93.65%53.28M
87.46%58.87M
69.69%39.43M
118.50%37.29M
-Other payable
----
-22.25%37.97M
----
-32.67%39.64M
----
30.96%48.84M
----
87.46%58.87M
----
118.50%37.29M
Non current liabilities due within one year
-98.47%1.24M
-38.85%31.21M
2,996.75%31.18M
12,416.81%81.11M
39,602.61%81.08M
81,425.93%51.04M
-97.49%1.01M
-98.92%648.04K
--204.21K
--62.61K
Other current liabilities
-51.12%1.46M
61.07%1.17M
-24.27%2.31M
49.10%831.75K
-94.79%2.99M
-99.27%728.85K
-22.99%3.06M
-41.78%557.84K
1,511.82%57.33M
6,690.55%100.47M
Total current liabilities
-42.62%485.28M
-14.46%620.43M
-17.18%637.31M
21.55%758.25M
32.53%845.71M
36.57%725.28M
60.89%769.54M
26.73%623.84M
7.95%638.11M
38.26%531.06M
Current liabilities
Estimate liabilities
----
----
----
----
----
0.00%1.99M
0.00%1.99M
0.00%1.99M
-29.28%1.99M
-29.28%1.99M
Deferred tax liabilities
-74.03%15.06M
-81.22%11.18M
-74.23%15.01M
-77.18%12.97M
20.27%58M
46.61%59.53M
76.46%58.25M
91.55%56.84M
435.82%48.22M
28.63%40.6M
Long term deferred income
12.52%67.51M
17.99%69.38M
-7.32%56.71M
-8.26%56.62M
13.75%60M
7.54%58.8M
8.07%61.19M
29.94%61.72M
11.08%52.74M
12.95%54.68M
Lease liabilities
-15.36%5.44M
-16.56%5.42M
-15.44%5.67M
-19.32%5.75M
-2.71%6.43M
-2.28%6.5M
--6.71M
--7.12M
--6.61M
--6.65M
Total non current liabilities
-29.26%88.01M
-45.17%85.98M
-71.15%77.4M
-71.87%75.34M
13.56%124.42M
50.90%156.82M
192.78%268.25M
238.25%267.79M
22.70%109.57M
25.53%103.92M
Total liabilities
-40.91%573.29M
-19.92%706.41M
-31.13%714.71M
-6.51%833.59M
29.75%970.13M
38.92%882.11M
82.09%1.04B
56.04%891.63M
9.89%747.68M
36.01%634.98M
Shareholders equity
Paid-in capital
-0.01%466.13M
-0.01%466.17M
-0.01%466.17M
-0.01%466.17M
0.12%466.17M
0.23%466.21M
0.23%466.21M
0.23%466.21M
0.10%465.59M
0.03%465.13M
Capital reserve funds
0.49%1.14B
0.48%1.14B
0.48%1.14B
0.48%1.14B
0.65%1.13B
1.45%1.14B
1.84%1.14B
1.84%1.14B
1.96%1.13B
1.37%1.12B
Surplus reserve funds
0.00%269.37M
0.00%269.37M
0.00%269.37M
0.00%269.37M
17.82%269.37M
17.82%269.37M
17.82%269.37M
17.82%269.37M
33.14%228.63M
33.14%228.63M
Retained profit
5.24%2B
6.16%1.89B
14.69%2.02B
18.89%1.93B
22.97%1.9B
25.41%1.78B
22.62%1.76B
20.82%1.63B
26.49%1.54B
26.66%1.42B
Less:Treasury stock
5,411.42%31.67M
2,633.29%30.58M
2,129.99%24.95M
-48.64%574.62K
-48.64%574.62K
-40.00%1.12M
-40.00%1.12M
-40.00%1.12M
--1.12M
--1.86M
Other composite income
--17.78M
--29.71M
--28.66M
--25.33M
----
----
----
----
----
----
Shareholders equity without minority interests
2.43%3.86B
3.16%3.76B
7.41%3.9B
9.69%3.84B
12.00%3.77B
12.98%3.65B
11.97%3.63B
10.89%3.5B
13.54%3.36B
12.89%3.23B
Minority interests
-21.11%1.44M
-11.82%1.66M
-4.40%1.88M
-1.88%2.03M
-19.21%1.82M
-19.89%1.88M
297.69%1.96M
370.48%2.07M
314.01%2.25M
--2.35M
Total shareholder equity
2.42%3.86B
3.15%3.76B
7.41%3.9B
9.68%3.84B
11.98%3.77B
12.96%3.65B
12.01%3.63B
10.94%3.5B
13.59%3.36B
12.97%3.23B
Total liabilityies and equity
-6.45%4.43B
-1.34%4.47B
-1.15%4.62B
6.39%4.67B
15.21%4.74B
17.22%4.53B
22.48%4.67B
17.86%4.39B
12.90%4.11B
16.21%3.87B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Huaxing Certified Public Accountants Firm (Special General Partnership)
--
--
--
Huaxing Certified Public Accountants Firm (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Assets
Current assets
Money funds -42.48%398.15M64.50%688.95M10.24%800.29M27.56%581.74M49.61%692.16M-31.79%418.82M32.74%725.98M-17.88%456.07M-77.13%462.63M-67.69%614M
Transactional financial assets -26.64%667.65M-18.63%645.32M13.03%695.12M10.40%745.04M69.15%910.04M188.48%793.04M153.12%614.96M216.90%674.83M156.20%538.01M30.91%274.9M
Notes receivable and accounts receivable -15.50%334.41M-28.16%297.76M-24.10%312.35M-18.45%331.41M-5.23%395.76M16.90%414.46M46.90%411.54M47.62%406.38M85.23%417.61M86.60%354.54M
-Notes receivable ---------------------58.43%43.37M448.59%70.31M1,005.53%82.67M211.88%105.47M1,400.67%104.32M
-Accounts receivable -15.50%334.41M-19.76%297.76M-8.46%312.35M2.38%331.41M26.79%395.76M48.31%371.1M27.64%341.23M20.87%323.71M62.88%312.14M36.70%250.22M
Other receivables (including interest and dividends) 41.26%4.82M17.33%4.9M-6.99%3.89M42.19%3.73M52.92%3.41M-17.28%4.18M-5.31%4.18M1.50%2.62M-33.01%2.23M46.92%5.05M
-Other receivable ----17.33%4.9M----42.19%3.73M-----17.28%4.18M----1.50%2.62M----46.92%5.05M
Advance payment -37.94%4.34M-61.71%3.83M-65.83%3.69M-15.72%7.69M-43.36%6.99M5.68%10M2.18%10.8M-11.30%9.12M-69.20%12.35M-59.67%9.46M
Inventories -29.26%110.57M-18.21%133.64M-15.70%146.44M-14.52%144.8M17.09%156.31M35.99%163.4M47.86%173.71M55.68%169.4M16.02%133.49M14.12%120.16M
Receivable financing --610--5.28M-100.00%108,256.80%11.74M---------82.23%2.84M-99.27%140.44K--2M--2.02M
Non-current assets due within one year -0.50%804.68M-23.89%753.58M-42.74%484.15M-44.35%468.74M162.06%808.71M1,256.01%990.17M47.32%845.47M46.04%842.33M--308.59M--73.02M
Other current assets --71.95M--38.09M--26.85M--271.2M------------------------
Total current assets -19.40%2.4B-7.97%2.57B-11.35%2.47B0.20%2.57B58.42%2.97B92.28%2.79B55.63%2.79B45.40%2.56B-28.30%1.88B-40.26%1.45B
Non Current assets
Other equity investment 46,910.29%94.02M50,370.91%100.94M49,846.86%99.89M48,185.89%96.57M33.33%200K33.33%200K33.33%200K33.33%200K0.00%150K50.00%150K
Fixed assets -----9.97%755.65M-----9.27%799.01M----8.10%839.29M----70.85%880.59M----48.49%776.4M
Constru in process ----693.78%74.7M----153.25%43.05M-----93.89%9.41M-----95.63%17M-----25.25%154.14M
Productive biological assets -3.23%8.7M--7.51M--8.77M--10.05M--8.99M--------------------
Intangible assets 1.18%59.57M-0.63%57.66M-0.76%58.52M0.19%60.03M4.16%58.87M0.96%58.03M2.64%58.97M4.67%59.91M0.18%56.52M3.06%57.47M
Goodwill 0.00%3.31M0.00%3.31M0.00%3.31M0.00%3.31M0.00%3.31M0.00%3.31M--3.31M--3.31M--3.31M--3.31M
Long deferred expense --1.21M--1.04M--1.11M--1.18M------------------------
Deferred tax assets -99.46%189.36K-99.23%246.87K-98.25%505.2K-98.88%299.89K51.21%34.86M64.13%31.87M61.16%28.9M64.69%26.8M15.98%23.06M18.65%19.42M
Usufruct assets -12.83%6.03M-12.13%6.33M-11.91%6.61M-12.82%6.79M6.20%6.92M7.30%7.21M--7.5M--7.79M--6.51M--6.72M
Other non current assets 25.48%1.02B13.19%892.11M24.95%1.14B30.06%1.08B-33.97%811.77M-43.51%788.13M-12.86%910.66M-15.42%834.13M1,867.06%1.23B1,403.47%1.4B
Total non current assets 15.36%2.04B9.33%1.9B13.96%2.15B15.05%2.11B-21.07%1.76B-27.99%1.74B-6.90%1.88B-6.84%1.83B118.19%2.24B169.84%2.41B
Total assets -6.45%4.43B-1.34%4.47B-1.15%4.62B6.39%4.67B15.21%4.74B17.22%4.53B22.48%4.67B17.86%4.39B12.90%4.11B16.21%3.87B
Liabilities
Current liabilities
Short term loan -75.00%57.04M-15.12%202.13M-37.52%155.08M57.02%206.65M225.67%228.16M693.18%238.15M2,378.61%248.19M629.98%131.6M45.74%70.06M-25.02%30.03M
Notes payable and accounts payable -24.92%135.18M-34.48%123.55M-45.80%120.83M-32.44%165.03M-29.47%180.04M-22.58%188.58M1.15%222.92M13.22%244.27M13.44%255.27M49.09%243.59M
-Notes payable -54.02%18.51M-20.59%17.48M-59.83%17.06M-31.88%32.69M17.03%40.24M-45.05%22.01M85.22%42.47M142.93%47.99M89.88%34.39M653.76%40.05M
-Accounts payable -16.54%116.67M-36.32%106.08M-42.50%103.76M-32.58%132.34M-36.71%139.79M-18.16%166.57M-8.61%180.44M0.15%196.27M6.75%220.89M28.76%203.54M
Contract liabilities -13.39%179.48M25.88%172.48M5.24%203.85M54.97%157.61M31.96%207.22M63.25%137.02M37.85%193.69M60.96%101.7M-21.95%157.03M-23.52%83.93M
Salaries payable -6.47%41.06M-5.44%30.67M-18.24%20.59M0.33%49.57M29.10%43.9M10.68%32.44M53.28%25.18M0.73%49.41M-26.00%34M-28.49%29.31M
Taxs payable -37.75%29.08M-25.46%21.23M184.43%63.18M57.14%57.82M88.56%46.71M346.79%28.48M14.24%22.21M-31.64%36.79M-43.78%24.77M-43.99%6.38M
Other payable (including interest and dividends) -26.75%40.74M-22.25%37.97M-24.36%40.3M-32.67%39.64M41.06%55.62M30.96%48.84M93.65%53.28M87.46%58.87M69.69%39.43M118.50%37.29M
-Other payable -----22.25%37.97M-----32.67%39.64M----30.96%48.84M----87.46%58.87M----118.50%37.29M
Non current liabilities due within one year -98.47%1.24M-38.85%31.21M2,996.75%31.18M12,416.81%81.11M39,602.61%81.08M81,425.93%51.04M-97.49%1.01M-98.92%648.04K--204.21K--62.61K
Other current liabilities -51.12%1.46M61.07%1.17M-24.27%2.31M49.10%831.75K-94.79%2.99M-99.27%728.85K-22.99%3.06M-41.78%557.84K1,511.82%57.33M6,690.55%100.47M
Total current liabilities -42.62%485.28M-14.46%620.43M-17.18%637.31M21.55%758.25M32.53%845.71M36.57%725.28M60.89%769.54M26.73%623.84M7.95%638.11M38.26%531.06M
Current liabilities
Estimate liabilities --------------------0.00%1.99M0.00%1.99M0.00%1.99M-29.28%1.99M-29.28%1.99M
Deferred tax liabilities -74.03%15.06M-81.22%11.18M-74.23%15.01M-77.18%12.97M20.27%58M46.61%59.53M76.46%58.25M91.55%56.84M435.82%48.22M28.63%40.6M
Long term deferred income 12.52%67.51M17.99%69.38M-7.32%56.71M-8.26%56.62M13.75%60M7.54%58.8M8.07%61.19M29.94%61.72M11.08%52.74M12.95%54.68M
Lease liabilities -15.36%5.44M-16.56%5.42M-15.44%5.67M-19.32%5.75M-2.71%6.43M-2.28%6.5M--6.71M--7.12M--6.61M--6.65M
Total non current liabilities -29.26%88.01M-45.17%85.98M-71.15%77.4M-71.87%75.34M13.56%124.42M50.90%156.82M192.78%268.25M238.25%267.79M22.70%109.57M25.53%103.92M
Total liabilities -40.91%573.29M-19.92%706.41M-31.13%714.71M-6.51%833.59M29.75%970.13M38.92%882.11M82.09%1.04B56.04%891.63M9.89%747.68M36.01%634.98M
Shareholders equity
Paid-in capital -0.01%466.13M-0.01%466.17M-0.01%466.17M-0.01%466.17M0.12%466.17M0.23%466.21M0.23%466.21M0.23%466.21M0.10%465.59M0.03%465.13M
Capital reserve funds 0.49%1.14B0.48%1.14B0.48%1.14B0.48%1.14B0.65%1.13B1.45%1.14B1.84%1.14B1.84%1.14B1.96%1.13B1.37%1.12B
Surplus reserve funds 0.00%269.37M0.00%269.37M0.00%269.37M0.00%269.37M17.82%269.37M17.82%269.37M17.82%269.37M17.82%269.37M33.14%228.63M33.14%228.63M
Retained profit 5.24%2B6.16%1.89B14.69%2.02B18.89%1.93B22.97%1.9B25.41%1.78B22.62%1.76B20.82%1.63B26.49%1.54B26.66%1.42B
Less:Treasury stock 5,411.42%31.67M2,633.29%30.58M2,129.99%24.95M-48.64%574.62K-48.64%574.62K-40.00%1.12M-40.00%1.12M-40.00%1.12M--1.12M--1.86M
Other composite income --17.78M--29.71M--28.66M--25.33M------------------------
Shareholders equity without minority interests 2.43%3.86B3.16%3.76B7.41%3.9B9.69%3.84B12.00%3.77B12.98%3.65B11.97%3.63B10.89%3.5B13.54%3.36B12.89%3.23B
Minority interests -21.11%1.44M-11.82%1.66M-4.40%1.88M-1.88%2.03M-19.21%1.82M-19.89%1.88M297.69%1.96M370.48%2.07M314.01%2.25M--2.35M
Total shareholder equity 2.42%3.86B3.15%3.76B7.41%3.9B9.68%3.84B11.98%3.77B12.96%3.65B12.01%3.63B10.94%3.5B13.59%3.36B12.97%3.23B
Total liabilityies and equity -6.45%4.43B-1.34%4.47B-1.15%4.62B6.39%4.67B15.21%4.74B17.22%4.53B22.48%4.67B17.86%4.39B12.90%4.11B16.21%3.87B
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Huaxing Certified Public Accountants Firm (Special General Partnership)------Huaxing Certified Public Accountants Firm (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data